Certara Launches CoAuthor, a Regulatory and Medical Writing Tool Announcement Certara Launches CoAuthor, a Regulatory and Medical Writing Tool Using AI to gain efficiencies for medical writers PRINCETON, N. J.— October 3, 2023— Certara,…CertaraOctober 3, 2023
Certara launches Phoenix Hosted, a cloud-based solution of Phoenix™ software Announcement Certara launches Phoenix Hosted, a cloud-based solution of Phoenix™ software Certara launches Phoenix Hosted, a cloud-based solution of Phoenix™ software PRINCETON, N.J.— September 19, 2023…CertaraSeptember 19, 2023
Certara Launches v11.0 of SEND Explorer Announcement Certara Launches v11.0 of SEND Explorer Delivers advanced data analysis and visualization capabilities to support nonclinical scientists PRINCETON, N.J.— August 28,…CertaraAugust 28, 2023
Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset Announcement Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset Software will aid optimizing pre-clinical data management in accordance with global standards and guidelines. Seoul,…CertaraAugust 3, 2023
Certara and Drugs for Neglected Diseases initiative (DNDi) Partnering to Fast-track Data Submissions and Accelerate Drug Approvals for Neglected Patients Announcement Certara and Drugs for Neglected Diseases initiative (DNDi) Partnering to Fast-track Data Submissions and Accelerate Drug Approvals for Neglected Patients DNDi Utilizing Pinnacle 21 Enterprise (P21E), Certara’s Data Science platform for Biostatistics, Data Management, and…CertaraJuly 31, 2023
DIDB® – The Drug Interaction Database, is now part of Certara Announcement DIDB® – The Drug Interaction Database, is now part of Certara PRINCETON, N.J.— June 20, 2023 — Certara, Inc. (Nasdaq: CERT), today announced it has acquired…CertaraJune 21, 2023
Certara Appoints new Chief Marketing Officer, Sheila Rocchio Announcement Certara Appoints new Chief Marketing Officer, Sheila Rocchio Princeton, N.J., June 13, 2023 – Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today…CertaraJune 14, 2023
Certara Launches Version 8.4 of Phoenix™ Biosimulation Software for Drug Development Announcement Certara Launches Version 8.4 of Phoenix™ Biosimulation Software for Drug Development Latest updates demonstrate commitment to customers and market leadership of Phoenix Platform PRINCETON, N.J.— June…CertaraJune 12, 2023
Certara enhances CODEX Clinical Outcome Analytics Platform with AI Announcement Certara enhances CODEX Clinical Outcome Analytics Platform with AI Trial design and execution now accelerated by deep learning and data fabric capabilities. PRINCETON, NJ…CertaraJune 8, 2023
Certara’s Synchrogenix Writer now enhanced with AI Layar Announcement Certara’s Synchrogenix Writer now enhanced with AI Layar Next generation automation for Medical Writers to streamline the creation of regulatory documents Certara is…CertaraMay 11, 2023